Evidence map›Paper›PMID 35587497›Full record

ArticlePLoS computational biology2022

CystiHuman: A model of human neurocysticercosis.

Gabrielle Bonnet, Francesco Pizzitutti, Eloy A Gonzales-Gustavson, Sarah Gabriël, William K Pan, Hector H Garcia, Javier A Bustos, Percy Vilchez, Seth E O'Neal, Cysticercosis Working Group in Peru

Open access · goldAbstract read
In one paragraph

Article in PLoS computational biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Human Neurocysticercosis: An Overview.Pathogens (Basel, Switzerland) · 2022
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Gabrielle BonnetIndependent Consultant for the School of Public Health, Oregon Health & Science University, Portland, Oregon, United States of America.ORCID 0000-0002-3539-5001
Francesco PizzituttiIndependent Consultant for the School of Public Health, Oregon Health & Science University, Portland, Oregon, United States of America.ORCID 0000-0002-5532-8770
Eloy A Gonzales-GustavsonTropical and Highlands Veterinary Research Institute, University of San Marcos, Lima, Peru.ORCID 0000-0001-7328-2983
Sarah GabriëlDepartment of Veterinary Public Health and Food Safety, Ghent University, Gent, Belgium.ORCID 0000-0002-2523-233X
William K PanNicholas School of Environment and Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America.ORCID 0000-0002-7407-7399
Hector H GarciaCenter for Global Health Tumbes, Universidad Peruana Cayetano Heredia, Lima, Peru.ORCID 0000-0002-4633-6269
Javier A BustosCenter for Global Health Tumbes, Universidad Peruana Cayetano Heredia, Lima, Peru.ORCID 0000-0002-5797-3052
Percy VilchezCenter for Global Health Tumbes, Universidad Peruana Cayetano Heredia, Lima, Peru.ORCID 0000-0001-5409-2703
Seth E O'NealCenter for Global Health Tumbes, Universidad Peruana Cayetano Heredia, Lima, Peru.ORCID 0000-0002-4782-3368
Cysticercosis Working Group in Peru
Universidad Peruana Cayetano Heredia · PEOregon Health & Science University · USDuke University · USGhent University · BEPortland State University · US

Funding

Development and validation of an agent-based model to promote evidence-based control of Taenia solium cysticercosisR01AI141554 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI O'NEAL, SETH E · 2019 to 2023
$3.3M
NIAID NIH HHS R01 AI141554
6 · The paper itself

Abstract

introductionThe Taenia solium tapeworm is responsible for cysticercosis, a neglected tropical disease presenting as larvae in the body of a host following taenia egg ingestion. Neurocysticercosis (NCC), the name of the disease when it affects the human central nervous system, is a major cause of epilepsy in developing countries, and can also cause intracranial hypertension, hydrocephalus and death. Simulation models can help identify the most cost-effective interventions before their implementation. Modelling NCC should enable the comparison of a broad range of interventions, from treatment of human taeniasis (presence of an adult taenia worm in the human intestine) to NCC mitigation. It also allows a focus on the actual impact of the disease, rather than using proxies as is the case for other models.

methodsThis agent-based model is the first model that simulates human NCC and associated pathologies. It uses the output of another model, CystiAgent, which simulates the evolution of pig cysticercosis and human taeniasis, adding human and cyst agents, including a model of cyst location and stage, human symptoms, and treatment. CystiHuman also accounts for delays in the appearance of NCC-related symptoms. It comprises three modules detailing cyst development, seizure probability and timing, and intracranial hypertension/hydrocephalus, respectively. It has been implemented in Java MASON and calibrated in three endemic villages in Peru, then applied to another village (Rica Playa) to compare simulation results with field data in that village. RESULTS AND DISCUSSION: Despite limitations in available field data, parameter values found through calibration are plausible and simulated outcomes in Rica Playa are close to actual values for NCC prevalence and the way it increases with age and cases with single lesions. Initial simulations further suggest that short-term interventions followed by a rapid increase in taeniasis prevalence back to original levels may have limited impacts on NCC prevalence.

Indexed as

CysticercosisCystsHydrocephalusIntracranial HypertensionNeurocysticercosisTaeniasisAnimalsHumansSwine

Identifiers

PMID35587497
PMCPMC9159625
OpenAlexW4280579836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.